Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.
Medical Research Center, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing 312000, China.
Pharmacol Res. 2024 Sep;207:107332. doi: 10.1016/j.phrs.2024.107332. Epub 2024 Jul 30.
The endoplasmic reticulum (ER) plays a pivotal role in protein folding and secretion, Ca storage, and lipid synthesis in eukaryotic cells. When the burden of protein synthesis and folding required to be handled exceeds the processing capacity of the ER, the accumulation of misfolded/unfolded proteins triggers ER stress. In response to short-term ER stress, the unfolded protein response (UPR) is activated to allow cells to survive. When ER stress is severe and sustained, it typically provokes cell death through multiple approaches. It is well documented that ER stress and metabolic deregulation are functionally intertwined, both are considered contributing factors to the pathogenesis of liver diseases, including non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), ischemia/reperfusion (I/R) injury, viral hepatitis, liver fibrosis, and hepatocellular carcinoma (HCC). Hepatocytes are rich in smooth and rough ER, which harbor metabolic enzymes that are capable of sensing alterations in various nutritional status and external stimuli. Extensive research has focused on the molecular mechanism linking ER stress with metabolic enzymes. The purpose of this review is to summarize the current knowledge regarding the effects of ER stress on metabolic enzymes in various liver diseases and to provide potential therapeutic strategies for chronic liver diseases via targeting UPR.
内质网(ER)在真核细胞的蛋白质折叠和分泌、Ca 储存和脂质合成中发挥着关键作用。当需要处理的蛋白质合成和折叠负担超过 ER 的处理能力时,错误折叠/未折叠蛋白质的积累会引发 ER 应激。为了应对短期的 ER 应激,未折叠蛋白反应(UPR)被激活,使细胞能够存活。当 ER 应激严重且持续时,它通常通过多种途径引发细胞死亡。有充分的文献记载表明,ER 应激和代谢失调在功能上是相互交织的,两者都被认为是导致肝脏疾病发病机制的因素,包括非酒精性脂肪性肝病(NAFLD)、酒精性肝病(ALD)、缺血/再灌注(I/R)损伤、病毒性肝炎、肝纤维化和肝细胞癌(HCC)。肝细胞富含光滑内质网和粗糙内质网,其中含有能够感知各种营养状态和外部刺激变化的代谢酶。大量研究集中在 ER 应激与代谢酶之间的分子机制上。本综述的目的是总结 ER 应激对各种肝脏疾病中代谢酶的影响的最新知识,并通过靶向 UPR 为慢性肝脏疾病提供潜在的治疗策略。